Gene Therapy Research Institution Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Investors
  • 7

Gene Therapy Research Institution General Information

Description

Developer of gene therapy intended to carry out research and development on neurodegenerative diseases. The company's drugs specialize in developing gene therapies for refractory diseases primarily focusing on Parkinson's disease, amyotrophic lateral sclerosis (ALS), and Alzheimer's disease, enabling patients to get therapies while suffering from refractory illnesses.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Life Innovation Center 414, 25-22
  • Tonomachi 3-chome, Kawasaki-ku, Kawasaki-sh
  • Kanagawa, 210-0821
  • Japan
+81 000-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Gene Therapy Research Institution Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series A) 31-Oct-2022 000.00 Completed Clinical Trials - Phase 2
4. Later Stage VC 24-Jun-2020 Completed Pre-Clinical Trials
3. Later Stage VC (Series A) 24-Dec-2019 Completed Pre-Clinical Trials
2. Secondary Transaction - Private 19-Feb-2016 $163K 00000 Cancelled Pre-Clinical Trials
1. Corporate Completed Pre-Clinical Trials
To view Gene Therapy Research Institution’s complete valuation and funding history, request access »

Gene Therapy Research Institution Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of gene therapy intended to carry out research and development on neurodegenerative diseases. The company's dr
Drug Discovery
Kanagawa, Japan
000.00 0000-00-00
00000000000

000000

uat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolor
0000000 000000000
Amsterdam, Netherlands
000 As of 0000
00000
000000&0 00000

000000

dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt u
0000000000000
Cranbury, NJ
000 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Gene Therapy Research Institution Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
uniQure Formerly VC-backed Amsterdam, Netherlands 000 00000 000000&0 00000
Rocket Pharmaceuticals Formerly VC-backed Cranbury, NJ 000 00000 00000000 00000
Sarepta Therapeutics Formerly VC-backed Cambridge, MA 0000 00000 00000000 00000
Regenxbio Formerly VC-backed Rockville, MD 000 00000 00000000 00000
BioMarin Pharmaceutical Formerly PE-Backed San Rafael, CA 0000 00000 0000 00000
You’re viewing 5 of 5 competitors. Get the full list »

Gene Therapy Research Institution Patents

Gene Therapy Research Institution Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4328313-A1 Adeno-associated virus virion for treating ornithine transcarbamylase deficiency Pending 21-Apr-2021 000000000
JP-2021097617-A Adeno-associated virus virion for treatment of ornithine transcarbamylase deficiency Pending 20-Dec-2019
US-20220265853-A1 Adeno-associated virus virion for gene transfer to human liver Pending 12-Jul-2019 000000000
EP-4006160-A1 Adeno-associated virus virion for gene transfer to human liver Pending 12-Jul-2019 0000000000
JP-7371954-B2 Adeno-associated virus virions for gene transfer into human liver Active 12-Jul-2019 C12N15/86 0
To view Gene Therapy Research Institution’s complete patent history, request access »

Gene Therapy Research Institution Executive Team (5)

Name Title Board Seat Contact Info
Katsuhito Asai Founder, Chief Executive Officer, President & Board Member
Shunta Nojiri Chief Financial Officer & Board Member
Sota Yoshizawa General Manager of Manufacturing & Board Member
Shin-ichi Muramatsu Ph.D Co-Founder, Chief Revenue Officer & Board Member
You’re viewing 4 of 5 executive team members. Get the full list »

Gene Therapy Research Institution Board Members (8)

Name Representing Role Since
Katsuhito Asai Gene Therapy Research Institution Founder, Chief Executive Officer, President & Board Member 000 0000
Shin-ichi Muramatsu Ph.D Gene Therapy Research Institution Co-Founder, Chief Revenue Officer & Board Member 000 0000
Shunta Nojiri Gene Therapy Research Institution Chief Financial Officer & Board Member 000 0000
Sota Yoshizawa Gene Therapy Research Institution General Manager of Manufacturing & Board Member 000 0000
Takashi Nishibori Gene Therapy Research Institution Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Gene Therapy Research Institution Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Healthcare Innovation Venture Capital Minority 000 0000 000000 0
PTC Therapeutics Corporation Minority 000 0000 000000 0
Sekisui Chemical Corporation Minority 000 0000 000000 0
Alfresa Holdings Corporation Minority 000 0000 000000 0
Environment Friendly Holdings Holding Company Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

Gene Therapy Research Institution Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Adeno-Associated Virus Gene Therapies (Agilis Biotherapeutics & Gene Therapy Research Institution) 02-Aug-2017 00000 0000 Biotechnology 000000000
To view Gene Therapy Research Institution’s complete investments history, request access »

Gene Therapy Research Institution FAQs

  • When was Gene Therapy Research Institution founded?

    Gene Therapy Research Institution was founded in 2014.

  • Who is the founder of Gene Therapy Research Institution?

    Katsuhito Asai and Shin-ichi Muramatsu Ph.D are the founders of Gene Therapy Research Institution.

  • Who is the CEO of Gene Therapy Research Institution?

    Katsuhito Asai is the CEO of Gene Therapy Research Institution.

  • Where is Gene Therapy Research Institution headquartered?

    Gene Therapy Research Institution is headquartered in Kanagawa, Japan.

  • What industry is Gene Therapy Research Institution in?

    Gene Therapy Research Institution’s primary industry is Drug Discovery.

  • Is Gene Therapy Research Institution a private or public company?

    Gene Therapy Research Institution is a Private company.

  • What is the current valuation of Gene Therapy Research Institution?

    The current valuation of Gene Therapy Research Institution is 000.00.

  • What is Gene Therapy Research Institution’s current revenue?

    The current revenue for Gene Therapy Research Institution is 000000.

  • Who are Gene Therapy Research Institution’s investors?

    Healthcare Innovation, PTC Therapeutics, Sekisui Chemical, Alfresa Holdings, and Environment Friendly Holdings are 5 of 7 investors who have invested in Gene Therapy Research Institution.

  • Who are Gene Therapy Research Institution’s competitors?

    uniQure, Rocket Pharmaceuticals, Sarepta Therapeutics, Regenxbio, and BioMarin Pharmaceutical are competitors of Gene Therapy Research Institution.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »